[{"address1": "1 Commonwealth Lane, No. 08-22", "city": "Singapore", "zip": "149544", "country": "Singapore", "phone": "65 6250 7738", "website": "https://w2.cytomed.sg", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "CytoMed Therapeutics Limited, a pre-clinical biopharmaceutical company, focuses on developing novel cell-based immunotherapies for the treatment of human cancers and degenerative diseases in Malaysia and Singapore. Its lead product candidate is CTM-N2D, an expanded gamma delta T cells grafted with natural killer group 2D ligands-targeting chimeric antigen receptor, which is in Phase I clinical trials comprising to improve anti-cancer cytotoxicity. The company is also developing iPSC-gdNKT, a pluripotent stem cell-derived gamma delta natural killer T cells platform for cancer treatment; CTM-GDT, a product candidate that consists of expanded allogeneic gamma delta T cells and exploits the potential of the cells to recognize and treat a broad range of cancers; and CTM-MSC, an injectable allogeneic umbilical cord derived mesenchymal stem cells for cartilage injury. It has research collaboration agreement with Sengkang General Hospital to provide CTM-MSC and its conditioned media for in vivo studies and Phase I clinical trial in Singapore. The company also has Business & Research Collaboration Agreement with SunAct Cancer Institute Private Limited to advance use of allogeneic off-the-shelf Gamma Delta T Cells for treatment of solid cancers. CytoMed Therapeutics Limited was incorporated in 2018 and is headquartered in Singapore.", "companyOfficers": [{"maxAge": 1, "name": "Mr. Chee Kong  Choo", "age": 66, "title": "Executive Chairman", "yearBorn": 1958, "fiscalYear": 2023, "totalPay": 27316, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Jieming  Zeng M.D., Ph.D.", "age": 50, "title": "Chief Scientific & Medical Officer and Director", "yearBorn": 1974, "fiscalYear": 2023, "totalPay": 89742, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Yvonne  Goh", "age": 34, "title": "Chief Financial Officer", "yearBorn": 1990, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Tien Wee  Luk M.D.", "age": 38, "title": "Chief Clinical Officer", "yearBorn": 1986, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Yoong Ying  Tan", "age": 35, "title": "Chief Corporate Officer", "yearBorn": 1989, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 2.51, "open": 2.52, "dayLow": 2.47, "dayHigh": 2.5638, "regularMarketPreviousClose": 2.51, "regularMarketOpen": 2.52, "regularMarketDayLow": 2.47, "regularMarketDayHigh": 2.5638, "payoutRatio": 0.0, "forwardPE": -16.533333, "volume": 4712, "regularMarketVolume": 4712, "averageVolume": 209566, "averageVolume10days": 11470, "averageDailyVolume10Day": 11470, "bid": 0.0, "ask": 0.0, "bidSize": 0, "askSize": 0, "marketCap": 28619200, "fiftyTwoWeekLow": 1.2, "fiftyTwoWeekHigh": 4.05, "priceToSalesTrailing12Months": 63.925663, "fiftyDayAverage": 2.6958, "twoHundredDayAverage": 2.214255, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 22223516, "profitMargins": 0.0, "floatShares": 2665855, "sharesOutstanding": 11540000, "sharesShort": 127762, "sharesShortPriorMonth": 190611, "sharesShortPreviousMonthDate": 1738281600, "dateShortInterest": 1740700800, "sharesPercentSharesOut": 0.0111, "heldPercentInsiders": 0.76899004, "heldPercentInstitutions": 0.0013, "shortRatio": 7.9, "shortPercentOfFloat": 0.0749, "impliedSharesOutstanding": 12509400, "bookValue": 0.881, "priceToBook": 2.8149831, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1719705600, "netIncomeToCommon": -3063187, "trailingEps": -0.22, "forwardEps": -0.15, "enterpriseToRevenue": 49.64, "enterpriseToEbitda": -7.122, "52WeekChange": 0.102222204, "SandP52WeekChange": 0.09506309, "quoteType": "EQUITY", "currentPrice": 2.48, "targetHighPrice": 5.0, "targetLowPrice": 5.0, "targetMeanPrice": 5.0, "targetMedianPrice": 5.0, "recommendationKey": "none", "numberOfAnalystOpinions": 1, "totalCash": 6822869, "totalCashPerShare": 0.591, "ebitda": -3120472, "totalDebt": 428285, "quickRatio": 19.199, "currentRatio": 21.534, "totalRevenue": 447695, "debtToEquity": 4.215, "revenuePerShare": 0.039, "returnOnAssets": -0.17438, "returnOnEquity": -0.26262, "grossProfits": 447856, "freeCashflow": -2590626, "operatingCashflow": -2555008, "revenueGrowth": -0.211, "grossMargins": 1.00036, "ebitdaMargins": 0.0, "operatingMargins": -7.3597302, "financialCurrency": "SGD", "symbol": "GDTC", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": true, "customPriceAlertConfidence": "HIGH", "corporateActions": [], "regularMarketChangePercent": -1.195218, "regularMarketPrice": 2.48, "regularMarketTime": 1741982400, "exchange": "NCM", "messageBoardId": "finmb_647650276", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "cryptoTradeable": false, "shortName": "CytoMed Therapeutics Limited", "longName": "CytoMed Therapeutics Limited", "marketState": "CLOSED", "regularMarketChange": -0.029999971, "regularMarketDayRange": "2.47 - 2.5638", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 209566, "fiftyTwoWeekLowChange": 1.28, "fiftyTwoWeekLowChangePercent": 1.0666666, "fiftyTwoWeekRange": "1.2 - 4.05", "fiftyTwoWeekHighChange": -1.5700002, "fiftyTwoWeekHighChangePercent": -0.38765433, "fiftyTwoWeekChangePercent": 10.22222, "epsTrailingTwelveMonths": -0.22, "epsForward": -0.15, "epsCurrentYear": -0.15, "priceEpsCurrentYear": -16.533333, "fiftyDayAverageChange": -0.21580005, "fiftyDayAverageChangePercent": -0.08005046, "twoHundredDayAverageChange": 0.26574492, "twoHundredDayAverageChangePercent": 0.120015495, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2023-04-14", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1681479000000, "displayName": "CytoMed Therapeutics", "trailingPegRatio": null, "__fetch_time": "2025-03-15"}]